CYP19A1 and ovarian carcinoma: The isoform of aromatase-ARO1 was found in TEXs of patients with ovarian cancer, and the ability of ARO+ TEXs to inhibit CD4 and CD8 cells was described by Czystowska-Kuzmicz et al. [149].